Neutrophil-mediated pulmonary vascular injury. Synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung.

The pathogenesis of acute lung injury in humans is obscure, but lipopolysaccharide (LPS), complement activation, and neutrophils have been implicated. We investigated in rabbits the interaction of small amounts of intravascularly administered LPS (100 ng) with neutrophil chemotactic factors, the synthetic chemotactic peptide formyl-norleucyl-leucyl-phenylalanine (FNLP), and the biologically relevant chemotactic fragments of C5 (C5f). These neutrophil stimuli produce neutropenia when injected intravascularly in rabbits, reflecting neutrophil adherence to vascular endothelium. When LPS was injected with FNLP, the duration of neutropenia was enhanced. Studies with radiolabeled neutrophils infused in vivo demonstrated prolonged neutrophil sequestration within the lung in rabbits that were given FNLP plus LPS, an effect that was visible for 4 h after injection. Morphometric analysis of tissue sections 4 h after infusion confirmed the presence of greater numbers of neutrophils in the lungs of animals receiving LPS and FNLP. When a combination of LPS and chemotactic factors was infused at both zero and 6 h, we found a marked enhancement of lung vascular permeability at 24 h (as assessed by radiolabeled albumin accumulation), an effect not seen with either LPS or chemotactic factor alone. Ultrastructural studies revealed neutrophil sequestration and alteration in endothelial cells in the animals that received the combination of LPS and chemotactic factors. Neutrophil depletion with nitrogen mustard completely abolished the increased vascular permeability seen in animals that received LPS and chemotactic factors. This study suggests that small amounts of intravascularly administered LPS enhance the sequestration of neutrophils within the lung and increase lung vascular permeability and endothelial injury caused by neutrophils stimulated by intravascularly administered chemotactic factors. This mechanism may be relevant to the production of acute lung injury in human beings.

[1]  C. Haslett,et al.  The pulmonary vascular sequestration of neutrophils in endotoxemia is initiated by an effect of endotoxin on the neutrophil in the rabbit. , 1987, The American review of respiratory disease.

[2]  J. Gamble,et al.  Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Cotran,et al.  Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. , 1985, The Journal of clinical investigation.

[4]  C. Haslett,et al.  Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. , 1985, The American journal of pathology.

[5]  G. Larsen,et al.  Additive effect of intravascular complement activation and brief episodes of hypoxia in producing increased permeability in the rabbit lung. , 1985, The Journal of clinical investigation.

[6]  L. Mcphail,et al.  Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme , 1984, The Journal of experimental medicine.

[7]  P A Ward,et al.  Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. , 1984, The Journal of biological chemistry.

[8]  B. Meyrick,et al.  The effect of a single infusion of zymosan-activated plasma on the pulmonary microcirculation of sheep. Structure-function relationships. , 1984, The American journal of pathology.

[9]  Dallas M. Hyde,et al.  A Guide to Practical Stereology , 1983 .

[10]  M. Gee,et al.  Role of prostaglandins and leukotrienes in complement-initiated lung vascular injury. , 1983, Chest.

[11]  B. Meyrick,et al.  Acute effects of Escherichia coli endotoxin on the pulmonary microcirculation of anesthetized sheep structure:function relationships. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[12]  G. Striker,et al.  Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[13]  J. Hogg,et al.  Effect of pulmonary blood flow on the exchange between the circulating and marginating pool of polymorphonuclear leukocytes in dog lungs. , 1982, The Journal of clinical investigation.

[14]  G. Larsen,et al.  PULMONARY MICROVASCULAR ALTERATIONS AND INJURY INDUCED BY COMPLEMENT FRAGMENTS: SYNERGISTIC EFFECT OF COMPLEMENT ACTIVATION, NEUTROPHIL SEQUESTRATION, AND PROSTAGLANDINS * , 1982, Annals of the New York Academy of Sciences.

[15]  P. Ward,et al.  Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. , 1982, The Journal of clinical investigation.

[16]  R. Rogers,et al.  Adult respiratory-distress syndrome: changing concepts of lung injury and repair. , 1982, The New England journal of medicine.

[17]  E. Weibel,et al.  Structural alterations of lung parenchyma in the adult respiratory distress syndrome. , 1982, Clinics in chest medicine.

[18]  B. Whipp,et al.  Hypopnea associated with acetate hemodialysis: carbon dioxide-flow-dependent ventilation. , 1981, The New England journal of medicine.

[19]  L. J. Weaver,et al.  ASSOCIATION OF COMPLEMENT ACTIVATION AND ELEVATED PLASMA-C5a WITH ADULT RESPIRATORY DISTRESS SYNDROME Pathophysiological Relevance and Possible Prognostic Value , 1980, The Lancet.

[20]  P. Henson,et al.  Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function. , 1980, Immunopharmacology.

[21]  R. Ulevitch,et al.  The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. , 1979, Journal of immunology.

[22]  H. Müller-Eberhard,et al.  Description of an Acidic Fragment (C3e) of Human C3 Having Leukocytosis-Producing Activity , 1978 .

[23]  R. Ulevitch,et al.  Role of complement in lethal bacterial lipopolysaccharide-induced hypotensive and coagulative changes , 1978, Infection and immunity.

[24]  A. Dalmasso,et al.  Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. , 1977, The Journal of clinical investigation.

[25]  L. Kline,et al.  Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). , 1977, Journal of immunology.

[26]  T. Hugli,et al.  Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a. , 1976, Journal of immunology.

[27]  G. Müller‐Berghaus,et al.  The Role of Complement in Endotoxin‐Induced Disseminated Intravascular Coagulation: Studies in Congenitally C6‐Deficient Rabbits , 1974, British journal of haematology.

[28]  E. Gaynor.  The role of granulocytes in endotoxin-induced vascular injury. , 1973, Blood.

[29]  L. Hinshaw,et al.  The pulmonary ultrastructure in septic shock. , 1970, Experimental and molecular pathology.

[30]  C. West,et al.  Serum C'3 Lytic System in Patients with Glomerulonephritis , 1969, Science.

[31]  M. Karnovsky,et al.  THE ULTRASTRUCTURAL BASIS OF ALVEOLAR-CAPILLARY MEMBRANE PERMEABILITY TO PEROXIDASE USED AS A TRACER , 1968, The Journal of cell biology.

[32]  Cornish Cb,et al.  MEDICAL TREATMENT OF OSTEOARTHRITIS. , 1965, Lancet.

[33]  J. Beazell,et al.  Measurement of Pulmonary Edema , 1965, Circulation research.

[34]  R. Walker,et al.  Distribution and clearance of circulating endotoxin. , 1963, The Journal of clinical investigation.

[35]  C. Stetson,et al.  STUDIES ON THE MECHANISM OF THE SHWARTZMAN PHENOMENON , 1949, The Journal of experimental medicine.